Enhancement of erectile function with renin-angiotensin...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/40 (2006.01) A61K 31/401 (2006.01) A61K 31/41 (2006.01) A61K 31/4178 (2006.01) A61K 31/675 (2006.01) A61K 38/05 (2006.01)

Patent

CA 2232360

A method for treating patients having erectile dysfunction is described. The method involves treating patients with a renin-angiotensin system inhibitor. A method for treating a subject to improve erectile function is also described. The method involves treating patients with a renin-angiotensin system inhibitor. Preferably the inhibitor is an angiotensin II antagonist, an ACE inhibitor, or a renin inhibitor.

L'invention se rapporte à un procédé de traitement de patients présentant une dysfonctionnement érectile. Ce procédé consiste à traiter des patients avec un inhibiteur du système rénine-angiotensine. L'invention se rapporte également à un procédé de traitement d'un patient dont on veut améliorer la fonction érectile. Ce procédé consiste à traiter des patients avec un inhibiteur du système rénine-angiotensine. De préférence, l'inhibiteur est un antagoniste de l'angiotensine II, un inhibiteur de l'enzyme convertissant l'angiotensine (ACE) ou un inhibiteur de rénine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Enhancement of erectile function with renin-angiotensin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Enhancement of erectile function with renin-angiotensin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhancement of erectile function with renin-angiotensin... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2087788

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.